Bronchial-pulmonary artery fistula with fatal massive hemoptysis caused by anastomotic bronchial aspergillus infection in a lung transplant recipient

Respiratory Care

Volumn 52, Issue 11, 2007, Pages 1542-1545

  Slatore, Christopher G ^a,d   Yank, Veronica ^b   Jewell, Kim D ^c   Fligner, Corinne L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CASPOFUNGIN; CIPROFLOXACIN; FLUCONAZOLE; HEPARIN; METRONIDAZOLE; PREDNISONE; TACROLIMUS; VANCOMYCIN; VORICONAZOLE;

ADULT; ARTICLE; BACTERIAL INFECTION; BRONCHOSCOPY; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOSTRIDIUM DIFFICILE; COLITIS; COLON RESECTION; DEEP VEIN THROMBOSIS; HEMOPTYSIS; HUMAN; LUNG ASPERGILLOSIS; LUNG BIOPSY; LUNG TRANSPLANTATION; MALE; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; TOXIC MEGACOLON; TRACHEOTOMY; VENTILATOR ASSOCIATED PNEUMONIA; WOUND INFECTION; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BIOPSY; BLOOD VESSEL FISTULA; BRONCHITIS; BRONCHUS FISTULA; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FATALITY; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BIOPSY; BRONCHIAL FISTULA; BRONCHITIS; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HEMOPTYSIS; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR FISTULA;

EID: 38549119640     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26(4):781-803.
2. Solé A, Morant P, Salavert M, Pemán J, Morales P. Aspergillus infections in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect 2005;11(5):359-365.
3. Nunley DR, Ohori NP, Grgurich WF, Iacono AT, Williams PA, Keenan RJ, Dauber JH. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998;114(5):1321-1329.
4. Nunley DR, Gal AA, Vega JD, Perlino C, Smith P, Lawrence EC. Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest 2002;122(4):1185-1191.
5. Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999;78(2):123-138.
6. Helmi M, Love RB, Welter D, Cornwell RD, Meyer KC. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest 2003;123(3):800-808.
7. Husain S, Kwak EJ, Obman A, Wagener MM, Kusne S, Stout JE, et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004;4(5):796-802.
8. Husain S, Paterson DL, Studer S, Pilewski J, Crespo M, Zaldonis D, et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006;6(12):3008-3016.
9. Herbrecht R, Denning DW, Patterson TF, Bennet JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347(6):408-415.
10. Pacetti SA, Gelone SP. Caspofungin acetate for treatment of invasive fungal infections. Ann Pharmacother 2003;37(1):90-98.
11. Ifran A, Kaptan K, Beyan C. Efficacy of caspofungin in prophylaxis and treatment of an adult leukemic patient with invasive pulmonary aspergillosis in allogeneic stem cell transplantation. Mycoses 2005;48(2):146-148.
12. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004;39(6):797-802.
13. Kessler R, Massard G, Warter A, Wihlm JM, Weitzenblum E. Bronchial-pulmonary artery fistula after unilateral lung transplantation: a case report. J Heart Lung Transplant 1997;16(6):674-677.